COVID-19 Updates
Latest News
Biden tests positive for COVID-19: White House
President Biden plans to isolate at the White House and “will continue to carry out all of his duties fully during that time.”
Feature
Methotrexate’s impact on COVID-19 vaccination: New insights made
New studies assess patients with various immune-mediated inflammatory diseases to determine the risks and benefits of pausing methotrexate after...
Livin' on the MDedge
Shift schedule today could worsen that stroke tomorrow
Plus: Feed your soul with online art, feed your “hangry” etymologist, but don’t feed anyone with SARS-CoV-2 from the freezer.
News from the FDA/CDC
FDA grants emergency authorization for Novavax COVID vaccine
Clinical trials found the vaccine to be 90.4% effective in preventing mild, moderate or severe COVID-19.
Latest News
WHO tracking new Omicron subvariant in India
BA.2.75 has eight mutations beyond those seen in BA.5, which “could make immune escape worse than what we’re seeing now.”
News
FDA panel strongly backs protein-based Novavax COVID-19 vaccine
“Having a protein-based alternative may be more comfortable for some in terms of their acceptance of vaccines.”
Conference Coverage
Immunosuppressed rheumatic patients not at high risk of breakthrough COVID-19
Patients with immunomodulated inflammatory diseases are not an at-risk group for breakthrough COVID-19 infections, apart from those on anti-CD20...
Conference Coverage
Pancreatic involvement in COVID-19: What do we know?
“Our data identify the human pancreas as a target of SARS-CoV-2 infection and suggest that pancreatic beta cell involvement could contribute to...
Latest News
Omicron breakthrough cases boost protection, studies say
“We should think about breakthrough infections as essentially equivalent to another dose of vaccine.”
News from the FDA/CDC
FDA authorizes Pfizer’s COVID booster for kids ages 5 to 11
“The omicron wave has seen more kids getting sick with the disease and being hospitalized, and children may also experience longer-term effects,...
Conference Coverage
Pfizer COVID vaccine performs well in youth with rheumatic diseases
Nearly all participants in the study showed complete seroconversion, in contrast to similar studies in adults.